title: AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
authors.affiliation: Dept. of Human Biotechnology and Hematology of the University La Sapienza of Roma, Via Benevento 6, 00161 Roma, Italy. mbreccia@hotmail.com
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cimino
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
authors.forename: Sara
authors.initials: S
authors.lastname: De Carolis
authors.forename: Francesco
authors.initials: F
authors.lastname: Lo Coco
authors.forename: Franco
authors.initials: F
authors.lastname: Mandelli
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002585:Cesarean Section; D003561:Cytarabine / Q000008:administration & dosage; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005260:Female; D005865:Gestational Age; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D007231:Infant, Newborn; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000209:etiology; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D012074:Remission Induction; D012306:Risk; D014212:Tretinoin / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014212:Tretinoin; D015255:Idarubicin